Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Jul 1;139(7):791-795.
doi: 10.1001/jamaophthalmol.2021.1551.

Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths

Affiliations
Observational Study

Racial/Ethnic Disparities and Barriers to Diabetic Retinopathy Screening in Youths

Chrystal G Thomas et al. JAMA Ophthalmol. .

Abstract

Importance: Diabetic retinopathy is a major complication of diabetes for which regular screening improves visual health outcomes, yet adherence to screening is suboptimal.

Objective: To assess disparities in diabetic eye examination completion rates and evaluate barriers in those not previously screened.

Design, setting, and participants: In this cohort study at a single academic center (Johns Hopkins Hospital pediatric diabetes center in Baltimore, Maryland) from December 2018 to November 2019, youths with type 1 or type 2 diabetes who met criteria for diabetic retinopathy screening and were enrolled in a prospective observational trial implementing point-of-care diabetic retinopathy screening were asked about prior diabetic retinopathy screening.

Main outcomes and measures: Demographic and clinical characteristics were compared between those who did and did not have a previous diabetic eye examination and stratified according to race/ethnicity, using t tests and χ2 tests. Multivariate logistic regression was used to analyze the association between race/ethnicity, screening, and other social determinants of health. A questionnaire assessing barriers to screening adherence was administered.

Results: Of 149 participants (76 male patients [51.0%]; mean [SD] age, 14.5 [2.3] years), 51 (34.2%) had not had a prior diabetic eye examination. These individuals were more likely than those who had prior diabetic eye examinations to be non-White youths (38 [75%] vs 31 [32%]; P < .001) and have type 2 diabetes (38 [75%] vs 10 [10%]; P < .001), Medicaid or public insurance (43 [84%] vs 31 [32%]; P < .001), lower household income (annual income ≤$25 000, 21 [41%] vs 9 [9%]; P < .001), and parents with education levels of high school or less (29 [67%] vs 22 [35%]; P < .001). The main barriers reported included not recalling being recommended to obtain a diabetic eye examination (19 [56%]), difficulty finding time for an additional appointment (10 [29%]), and transportation issues (7 [20%]). Minority youths were less likely to have a previous diabetic eye examination (non-White, 34 [46%] vs White, 64 [85%]; P < .001) and more likely to have diabetic retinopathy (11 [15%] v 2 [3%]; P = .008). Minority youths were less likely to get diabetic eye examinations even after adjusting for insurance, household income, and parental education level (odds ratio, 0.29 [95% CI, 0.10-0.79]; P = .02).

Conclusions and relevance: In this cohort study, non-White youths were less likely to undergo diabetic eye examinations yet more likely to have diabetic retinopathy compared with White youths. Addressing barriers to diabetic retinopathy screening may improve access to diabetic eye examination and facilitate early detection.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Wolf reports receiving financial support from Boehringer Ingelheim outside the submitted work. Dr Abramoff reports being an employee, investor, and director of Digital Diagnostics during the conduct of the study and outside the submitted work and holding patents and patent applications assigned to the University of Iowa and Digital Diagnostics that are relevant to the subject matter of this article, with royalties paid. No other disclosures were reported.

Figures

Figure.
Figure.. Reported Barriers to Diabetic Retinopathy Screening
Of 34 respondents, 19 (56% [95% CI, 37%-73%]) reported communication issues, 10 (29% [95% CI, 15%-48%]) reported time constraints, 7 (20% [95% CI, 87%-38%]) reported transportation issues, and 2 (6% [95% CI, 1%-20%]) reported cost issues as barriers to undergoing a diabetic eye examination.

References

    1. Lueder GT, Silverstein J; American Academy of Pediatrics Section on Ophthalmology and Section on Endocrinology . Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. 2005;116(1):270-273. doi:10.1542/peds.2005-0875 - DOI - PubMed
    1. American Diabetes Association . 13, Children and adolescents: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(suppl 1):S163-S182. doi:10.2337/dc20-S013 - DOI - PubMed
    1. Wang SY, Andrews CA, Gardner TW, Wood M, Singer K, Stein JD. Ophthalmic screening patterns among youths with diabetes enrolled in a large us managed care network. JAMA Ophthalmol. 2017;135(5):432-438. doi:10.1001/jamaophthalmol.2017.0089 - DOI - PMC - PubMed
    1. Wolf RMLT, Liu TYA, Thomas C, et al. . The SEE study: safety, efficacy and equity of implementing autonomous artificial intelligence for diagnosing diabetic retinopathy in youth. Diabetes Care. 2021;44(3):781-787. doi:10.2337/dc20-1671 - DOI - PubMed
    1. Graham-Rowe E, Lorencatto F, Lawrenson JG, et al. . Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature. Diabet Med. 2018;35(10):1308-1319. doi:10.1111/dme.13686 - DOI - PubMed

Publication types